Aims. Brittle cornea syndrome (BCS) is a rare autosomal recessive disorder. The aim of this study was to review ZNF469 mutations associated with BCS type 1 to date and to describe an additional case of Czech/Polish background. Methods. Whole genome sequencing was undertaken to identify the molecular genetic cause of disease in the proband. Sequence variants in ZNF469 previously reported as BCS type 1-causing were searched in the literature, manually curated and aligned to the reference sequence NM_001127464.2. Results. The proband has been reviewed since childhood with progressive myopia and hearing loss. Aged 13 years had been diagnosed with Stickler syndrome. Aged 16.5 years, he developed acute hydrops in the left eye managed by corneal transplantation. At the age of 26, he experienced right corneal rupture after blunt trauma, also managed by grafting. He had a number of secondary complications and despite regular follow-up and timely management, the right eye became totally blind and the left eye had light perception at the last follow-up visit, aged 42. He was found to be a compound heterozygote for two novel mutations c.1705C>T; p.(Gln569*) and c.1402_1411del; p.(Pro468Alafs*31) in ZNF469. In total 22 disease-causing variants in ZNF469 have been identified, mainly in consanguineous families or endogamous populations. Only four probands, including the case described in the current study, harboured compound heterozygous mutations. Conclusion. BCS occurs very rarely in outbred populations which may cause diagnostic errors due to poor awareness of the disease. Investigation into the underlying molecular genetic cause in patients with connective tissue disorders may lead to a re-evaluation of their clinical diagnosis.
INTRODUCTION
Brittle cornea syndrome (BCS) is a rare generalized connective tissue disorder inherited as an autosomal recessive trait. Clinical ocular features include fragile thin ectatic corneas and blue sclerae. Variable commonly associated extraocular manifestations comprise skeletal and/or connective tissue abnormalities, such as joint hypermobility with occasional dislocations, kyphoscoliosis, hyperlaxity of the skin, dental abnormalities and hearing loss which develops in around one third of cases 1, 2 . Mutations within two genes ZNF469 (ref. 2, 3 ) and PRDM5 (ref. 4, 5 ) are known to be associated with BCS type 1 (BCS1; MIM #229200) and type 2 (BCS2; MIM #614170), respectively. The disease mechanism remains unclear. Both encoded proteins ZNF469 and PRDM5 are transcription factors regulating extracellular matrix components, particularly fibrillar collagens suggesting involvement in the same pathway 3, 5, 6 . In this review we summarize and evaluate for pathogenicity using recent bioinformatics tools all variants in ZNF469 previously reported as BCS1-causing including two novel ZNF469 mutations identified in a case of Czech/Polish descent under ophthalmic review for 26 years.
MATERIALS AND METHODS
The study was approved by the Ethics committee of General University in Prague and adhered to the Declaration of Helsinki. Informed consents were signed prior to the start of all investigations.
DNA from the proband and participating family members was extracted from a venous blood sample using the Gentra Puregene blood kit (Qiagen, Hilden, Germany) and analysed by genome sequencing using a TruSeq Nano DNA library preparation kit and a HiSeq X Ten sequencer (Illumina). FASTQ reads were aligned to the GRCh38/ hg38 human reference sequence using the BurrowsWheeler Alignment tool 7 . Variant calling was performed with HaplotypeCaller 8 . Sequence changes with a minor allele frequency <0.005 in ZNF469 and PRDM5 were prioritized for further evaluation. Conventional Sanger sequencing was applied to show segregation of the detected mutation within the family 9 . Sequence variants previously reported as causing BCS1 were searched in the literature, manually curated and aligned to the reference sequence NM_001127464.2. Missense variants were subjected to in silico analysis using 6 different tools. The population frequency of the variants was retrieved from the Genome Aggregation Database (gnomAD), providing sequencing data from more than 138,000 unrelated individuals of various ethnic backgrounds 10 , and 4,528 Czech control chromosomes available through the projects of the National Center for Medical Genomics (https://ncmg.cz/en).
RESULTS

CASE REPORT
The proband of Czech/Polish descent was under ophthalmic review from his 3 rd birthday because of progressive myopia. According to his clinical notes, he was diagnosed with bilateral corneal ectasia before the age of (Fig. 1E) . Blue sclerae were also noticed bilaterally (Fig. 1B, H) . Right cornea was ectatic (Fig. 1A) . No other abnormalities of iris, pupil, lens or retina were noted. Penetrating keratoplasty was performed two months later in view of persistence of the corneal edema and light perception visual acuity in the affected eye. Unfortunately, the patient suffered from immunological rejection and graft failure (Fig. 1F) . Two repeated keratoplasties were therefore performed at the age of 17.5 and 20 years complicated by increased intraocular pressure (IOP) necessitating trabeculectomy. Eighteen months after the third keratoplasty, BCVA was 0.16 in the left eye. Thereafter the graft gradually failed (Fig. 1G ) and 23 years following his examination (now aged 42) BCVA in the left eye was light perception. IOP remained controlled. At the age of 26, the patient experienced right corneal rupture with lens dislocation after blunt trauma. Tectonic penetrating keratoplasty was performed. Five months after the surgery, the right retina detached and the patient underwent pars plana vitrectomy and silicone oil tamponade. Unfortunately, uncontrollable secondary glaucoma caused progressive BCVA decline. The corneal graft in the right also failed and became opaque (Fig. 1C) . Since the age of 32, the right eye was totally blind. Progression of scleral ectasia was documented (Fig. 1B,C,D) . Table 1 lists all surgeries the patient underwent since the age of 16.5 years.
In addition, the proband had been followed up since childhood (11 years of age) for sensorineural hearing loss, managed with a hearing aid. Repeated audiometry confirmed the presence of moderate symmetrical nonprogressive impairment in both ears with a loss in the range of 45-65 dB. Mild worsening was observed with age and deemed to be age-associated.
Transthoracic echocardiography was performed at the age of 17 and 26 years. Mitral and tricuspid valve insufficiencies were noted but not deemed functionally important. Incomplete right bundle branch block was also detected on electrocardiography and considered benign, not requiring treatment. Aged 26 years the patient's height was 190 cm and his weight was 60 kg, with concomitant mild kyphoscoliosis, clinodactyly and hallux valgus (Fig. 2) . No joint subluxations, fractures, abnormal contractures or severe bone deformities were found. No skin striae, excessive scarring, bruising or abnormal laxity were observed. At the age of 31, the proband underwent surgery for right scrotal hernia. Of note, he also suffered from excessive dental caries since childhood. Details of dental examinations were however unavailable.
Importantly, since the age of 13 he had been considered to be a de novo case of Stickler syndrome. This diagnosis remained unchallenged until the age of 40, when a clinical diagnosis of BCS based on careful review of his past clinical notes was suspected.
Molecular genetic diagnosis uncovered compound heterozygosity for c.1705C>T; p.(Gln569*) and c.1402_1411del; p.(Pro468Alafs*31) in ZNF469 (Fig.3) , absent from gnomAD as well as from white Czech control chromosomes, confirming BCS1. As truncating mutations have been previously associated with BCS1 (Table  2) , these variants were considered pathogenic. Consistent with autosomal recessive disease, both parents were heterozygous carriers of each detected variants. Two unaffected sisters were also heterozygous carriers (Fig. 3) .
Summary of ZNF469 mutations causing BCS1
Including this study, there are 22 different sequence variants reported as pathogenic in 24 families with more than 40 family members affected by BCS1 (Table 2) . Only four probands were compound heterozygotes, the rest were homozygotes.
None of the mutations had an entry in gnomAD. Sixteen reported variants are predicted to result in the interruption of translation, consequently leading either to a truncation of the encoded protein, or degradation of aberrant transcripts by nonsense-mediated mRNA decay 11 . One mutation was a large deletion encompassing the whole ZNF469 gene. Two variants were missense mutations 1, 12, 13 . Pathogenicity predictions using six software tools supported the disease-causing role of the two missense mutations (Table 3) .
One additional variant reported as disease-causing c.7424C>A; p.(Ala2475Glu) (ref. 13 ) was discarded because of its high prevalence in the general population (minor allele frequency 0.07422, with 567 homozygotes reported as per gnomAD), not matching the rarity of BCS1.
DISCUSSION
BCS1 is an ultra-rare disease. In addition to a comprehensive curation and summary of all 22 disease-causing mutations in ZNF469 associated with BCS1 reported to date, we present a case harbouring two novel pathogenic variants detected by genome sequencing.
Analysis using current bioinformatic tools, especially interrogation of publicly available minor allele frequencies, allowed us to dismiss one ZNF469 variant previously associated with BCS1 highlighting the general fact that there is a need of re-evaluation of mutational findings published before the era of large datasets. BCS1 has been caused by homozygous mutations in the great majority of families, which is consistent with consanguinity and/ or marriages within endogamous populations. The function of ZNF469 has not been fully resolved, however the importance of the protein on corneal structure and development has been recently confirmed, showing association with keratoconus and central corneal thickness 9, 14 . Although the phenotype in our proband was typical it took more than two decades to make the correct diagnosis. His clinical course confirms the fact that management of corneal rupture in BCS is difficult and outcomes are usually unsatisfactory despite state-of-the-art treatment 15, 16 . It is therefore of utmost importance to recognize BCS early, in order to apply preventive measures. As a part of our long-term follow-up we have also documented sensorineural hearing impairment with no progression other than age-related mild decline.
CONCLUSION
BCS1 occurs very rarely in outbred populations which may cause diagnostic errors due to poor awareness of the disease. Molecular genetic analysis evolved to be an essential part of the diagnostic process in many rare diseases including BCS, and in some cases, it may even lead after many years to a correction of the clinical diagnosis.
Search strategy and selection criteria
Our research strategy was aimed at identifying studies reporting on ZNF469 mutations associated with BCS1. Scientific articles from 1999 to December 2018 were searched using the PubMed and Scopus databases. The search terms used included "brittle cornea syndrome", "ZNF469", "mutation", "variant". All relevant articles were reviewed. 
